Brightseed Analysis: $120M Raised
What is Brightseed?
Brightseed is a pioneer in biosciences and artificial intelligence that identifies bioactive compounds in nature to restore human health. Their unique Forager AI platform accelerates the discovery of these compounds, connecting them to specific health benefits. This innovative approach enables faster validation of health solutions derived from natural sources.
HQ Country
San Francisco, United States
Employees
51-200
Founded
2017
Industry
AI/ML, Biotech, HealthTech
Product Features & Capabilities
- Forager AI platform for bioactive discovery
- Bioactive Profiler for health insights
- Bioactive Ingredient Finder for novel plant sources
- Bio Gut Fiber for gut health
- Bio Gut Core for enhanced gut health solutions.
How much Brightseed raised
Series A - $25M
June 11, 2020Lead Investor: S2G Ventures, AgFunder, and 4 more
Series A - $27M
September 15, 2020Lead Investor: Lewis & Clark Agrifood, S2G Ventures, and 5 more
Series B - $68M
May 09, 2022Lead Investor: Temasek, Lewis & Clark Agrifood, and 4 more
Grant - N/A
December 19, 2023Lead Investor: Bill & Melinda Gates Foundation, Angel Collective Opportunity Fund
Financial Overview
$120MTotal Raised
Series A$25M
June 11, 2020
Investors: S2G Ventures, AgFunder, and 4 more
Series A$27M
September 15, 2020
Investors: Lewis & Clark Agrifood, S2G Ventures, and 5 more
Series B$68M
May 09, 2022
Investors: Temasek, Lewis & Clark Agrifood, and 4 more
Grant
December 19, 2023
Investors: Bill & Melinda Gates Foundation, Angel Collective Opportunity Fund
